Coronavirus: FDA authorises remdesivir drug for Covid-19, says Trump

WASHINGTON (REUTERS) – The US Food and Drug Administration (FDA) has granted authorisation to Gilead Sciences Inc for emergency use of its experimental antiviral drug remdesivir to treat patients with Covid-19, it said in a letter to Gilead.

During a meeting in the Oval Office with President Donald Trump, Gilead chief executive Daniel O’Day called the move an important first step and said the company was donating one million vials of the drug to help patients.

Trump listens during an event with Gilead Sciences at the White House, May 1, 2020.PHOTO: REUTERS

Gilead said on Wednesday the drug had helped improve outcomes for patients with Covid-19, the disease caused by the coronavirus, and provided data suggesting it worked better when given earlier in the course of infection.

The closely watched drug has moved financial markets in recent weeks, following the release of several studies that painted a mixed picture of its effectiveness.

Vice-President Mike Pence said the one million vials would start being distributed to hospitals on Monday.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s